Xing Gao
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Immunology top 10%
- Immunotherapy and Immune Responses
Papers in
-
- Inflammasome and immune disorders 4
- Oncology 14
- Co-authors
- Faming Pan (21 shared papers)Jixiang Deng (18 shared papers)Kezhen Yi (1 shared paper)Xuan Tang (1 shared paper)Lanxiang Huang (1 shared paper)Jinxuan Hou (1 shared paper)Chunhui Yuan (1 shared paper)Jiazhou Ye (17 shared papers)
In The Last Decade
Xing Gao
94 papers receiving 1.7k citations
Xing Gao's Hit Papers
Peers
Comparison fields: 5 of 115
- Cancer Research 270
- Immunology 326
- Rheumatology 162
- Hepatology 77
- Periodontics 41
Countries citing papers authored by Xing Gao
This map shows the geographic impact of Xing Gao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xing Gao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xing Gao more than expected).
Fields of papers citing papers by Xing Gao
This network shows the impact of papers produced by Xing Gao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xing Gao. The network helps show where Xing Gao may publish in the future.
Co-authors
The 25 scholars most cited alongside Xing Gao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 99 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Engineered exosomes as an in situ DC-primed vaccine to boost antitumor immunity in breast cancer Hit paper breakdown → | 2022 | 328 |
| 2 | 2020 | 102 | |
| 3 | 2021 | 59 | |
| 4 | 2022 | 50 | |
| 5 | 2018 | 47 | |
| 6 | 2013 | 45 | |
| 7 | 2022 | 44 | |
| 8 | 2021 | 40 | |
| 9 | 2021 | 40 | |
| 10 | 2022 | 34 | |
| 11 | 2022 | 33 | |
| 12 | 2022 | 33 | |
| 13 | 2019 | 33 | |
| 14 | 2022 | 32 | |
| 15 | 2019 | 32 | |
| 16 | 2021 | 29 | |
| 17 | 2019 | 28 | |
| 18 | 2019 | 27 | |
| 19 | 2021 | 26 | |
| 20 | 2008 | 26 |
About Xing Gao
Xing Gao is a scholar working on Molecular Biology, Oncology, Rheumatology, Cancer Research and Biomedical Engineering, having authored 99 papers that have together received 1.7k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (9 papers), Spondyloarthritis Studies and Treatments (9 papers), Nanoplatforms for cancer theranostics (8 papers), Salivary Gland Disorders and Functions (5 papers), Cancer, Lipids, and Metabolism (5 papers), Rheumatoid Arthritis Research and Therapies (4 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Inflammasome and immune disorders (4 papers). The work is most often cited by research in Cancer Research (270 citations), Immunology (326 citations), Rheumatology (162 citations), Hepatology (77 citations) and Periodontics (41 citations). Xing Gao has collaborated with scholars based in China, Germany and Australia. Frequent co-authors include Faming Pan, Jixiang Deng, Kezhen Yi, Xuan Tang, Lanxiang Huang, Jinxuan Hou, Chunhui Yuan, Jiazhou Ye, Gang Liu and Weihuang Liu. Their work appears in journals such as Advanced Functional Materials, Scientific Reports, Frontiers in Bioengineering and Biotechnology, Immunological Investigations and Modern Rheumatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.